|
Klebsiella pneumoniae Infections - Pipeline Review, H2 2018 |
Oct 23 2018 |
127 |
Global |
$2,000.00 |
|
|
Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2018 |
Oct 16 2018 |
87 |
Global |
$3,500.00 |
|
|
Women Infertility - Pipeline Review, H2 2018 |
Oct 16 2018 |
202 |
Global |
$2,000.00 |
|
|
Radiation Injury - Pipeline Review, H2 2018 |
Oct 16 2018 |
50 |
Global |
$2,000.00 |
|
|
Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H2 2018 |
Oct 16 2018 |
36 |
Global |
$3,500.00 |
|
|
Rabies - Pipeline Review, H2 2018 |
Oct 16 2018 |
77 |
Global |
$2,000.00 |
|
|
Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Oct 16 2018 |
35 |
Global |
$3,500.00 |
|
|
Peanut Allergy - Pipeline Review, H2 2018 |
Oct 16 2018 |
117 |
Global |
$2,000.00 |
|
|
Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2018 |
Oct 16 2018 |
62 |
Global |
$3,500.00 |
|
|
Rhabdomyosarcoma - Pipeline Review, H2 2018 |
Oct 16 2018 |
307 |
Global |
$2,000.00 |
|
|
Keratitis - Pipeline Review, H2 2018 |
Oct 16 2018 |
62 |
Global |
$2,000.00 |
|
|
Hepatitis D - Pipeline Review, H2 2018 |
Oct 16 2018 |
69 |
Global |
$2,000.00 |
|
|
Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 |
Oct 16 2018 |
50 |
Global |
$3,500.00 |
|
|
Allergic Conjunctivitis - Pipeline Review, H2 2018 |
Oct 16 2018 |
81 |
Global |
$2,000.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) - Pipeline Review, H2 2018 |
Oct 16 2018 |
109 |
Global |
$3,500.00 |
|
|
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2018 |
Oct 16 2018 |
123 |
Global |
$3,500.00 |
|
|
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018 |
Oct 16 2018 |
116 |
Global |
$2,000.00 |
|
|
Measles - Pipeline Review, H2 2018 |
Oct 16 2018 |
39 |
Global |
$2,000.00 |
|
|
Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 |
Oct 16 2018 |
69 |
Global |
$3,500.00 |
|
|
Cataract - Pipeline Review, H2 2018 |
Oct 16 2018 |
45 |
Global |
$2,000.00 |
|
|
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Pipeline Review, H2 2018 |
Oct 16 2018 |
118 |
Global |
$3,500.00 |
|
|
Glycoprotein 41 (gp41) - Pipeline Review, H2 2018 |
Oct 16 2018 |
66 |
Global |
$3,500.00 |
|
|
Premature Ejaculation - Pipeline Review, H2 2018 |
Oct 16 2018 |
41 |
Global |
$2,000.00 |
|
|
Cancer Pain - Pipeline Review, H2 2018 |
Oct 16 2018 |
123 |
Global |
$2,000.00 |
|
|
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Oct 16 2018 |
56 |
Global |
$3,500.00 |
|
|
Corneal Neovascularization - Pipeline Review, H2 2018 |
Oct 16 2018 |
38 |
Global |
$2,000.00 |
|
|
Neurofibromatoses Type II - Pipeline Review, H2 2018 |
Oct 16 2018 |
50 |
Global |
$2,000.00 |
|
|
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018 |
Oct 16 2018 |
88 |
Global |
$3,500.00 |
|
|
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2018 |
Oct 16 2018 |
51 |
Global |
$2,000.00 |
|
|
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2018 |
Oct 16 2018 |
92 |
Global |
$3,500.00 |
|
